Envoy Medical, Inc. (COCH) Key Statistics & Financial Ratios

Envoy Medical, Inc. (COCH) — Price $0.71 HealthcareMedical - Devices — NASDAQ

Latest reported results:

Key statistics dashboard for Envoy Medical, Inc. (COCH). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.

Envoy Medical, Inc. is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss. Its diverse product portfolio includes conventional hearing aids, Esteem middle ear implants, bone conduction devices, and Acclaim cochlear implants. Established in 1995, the company originally operated as St. Croix Medical, Inc. before officially rebranding to Envoy Medical, Inc. in December 2004. Envoy Medical, Inc.

Stock Data

Price$0.71
Market Cap$15M
Enterprise Value-$4.1M
Beta2.05
ExchangeNASDAQ
CountryUS

Valuation Multiples

P/E Ratio-1.06
Price / Book22.36
P/S71.34
EV/EBITDA0.19
EV/Sales-19.80
EV/FCF0.19
P/FCF-0.68
Earnings Yield-31.68%
FCF Yield-146.99%
Dividend Yield0.00%

Profitability

Gross Margin-385.51%
EBIT Margin-10678.26%
EBITDA Margin-10567.63%
Operating Margin-11411.11%
Net Margin-11304.83%
Return on Equity1719.71%
Return on Assets-97.71%
Return on Invested Capital-206.35%
Return on Capital Employed-208.76%

Financial Health

Current Ratio1.73
Quick Ratio1.61
Cash Ratio1.56
Debt / Equity0.25
Debt / Assets3.38%
Net Debt / EBITDA0.86
Interest Coverage-50.15

Per-Share Data

Revenue per share0.00
Book Value per share0.03
Cash per share0.19
FCF per share-0.21
Tangible Book Value per share0.03
Dividend per share0.00

Related companies: ADGM · ADTX · ALUR · ATHA · CODX · HCTI · IRIX

Explore sector: Healthcare · Medical - Devices

More sections of COCH: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks